Overview

Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
To investigate the safety and efficacy of long-term treatment with pioglitazone (Actos tablets) in combination with biguanides (for 12 months after the start of pioglitazone tablets treatment) in patients with type 2 diabetes mellitus.
Details
Lead Sponsor:
Takeda
Treatments:
Pioglitazone